Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.

@article{Bianco2008MorbidityCO,
  title={Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.},
  author={Paola Del Bianco and Giorgio Zavagno and Paolo Burelli and Giuliano Scalco and Luca Barutta and Paolo Carraro and Paolo Pietrarota and Graziano Meneghini and Tiziana Morbin and Giovanni Tacchetti and Pierluigi Pecoraro and Valentina Belardinelli and Gian Luca de Salvo},
  journal={European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology},
  year={2008},
  volume={34 5},
  pages={508-13}
}
AIMS To compare physical morbidity and health-related quality of life (HRQOL) in breast cancer patients who received standard axillary dissection (ALND) or sentinel lymph node biopsy (SLNB), followed by axillary dissection only in the case of sentinel-node positivity, within a randomised clinical trial. PATIENTS AND METHODS Patients with early breast cancer < or =3cm and clinically negative axilla were randomly allocated to ALND or SLNB. All patients underwent physical examination every 6… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 64 extracted citations

Breast Cancer Management for Surgeons

Springer International Publishing • 2018
View 11 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…